MYL3 antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
MYL3 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab05487
tested applications
ELISA, IHC, WB, IP
Description
Regulatory light chain of myosin. Does not bind calcium.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | myosin, light chain 3, alkali; ventricular, skeletal, slow (MYL3) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1:500-1:2000; IHC: 1:50-1:500; IP: 1:2000-1:4000 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 22-27 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, IHC, WB, IP |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | P08590 |
Gene ID | 4634 |
Alias | Myosin light chain 3,Cardiac myosin light chain 1 (CMLC1),Myosin light chain 1, slow-twitch muscle B/ventricular isoform (MLC1SB),Ventricular myosin alkali light chain,Ventricular myosin light chain 1 (VLCl),Ventricular/slow twitch myosin alkali light chain (MLC-lV/sb),MYL3 |
Background | Antibody anti-MYL3 |
Status | RUO |
Note | Mol. Weight 22-27 kDa |
Descripción
Related Products


MYL3 antibody
MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
Ver Producto
Myosin Light Chain 3 (MYL3) Antibody
MYL3 Antibody is a Rabbit Polyclonal antibody against MYL3. MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
Ver Producto